317 related articles for article (PubMed ID: 11842444)
21. Mechanisms underlying the honokiol inhibition of evoked glutamate release from glutamatergic nerve terminals of the rat cerebral cortex.
Sy HN; Wu SL; Wang WF; Wang SJ
Synapse; 2008 Dec; 62(12):890-901. PubMed ID: 18792989
[TBL] [Abstract][Full Text] [Related]
22. Memantine depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase C in rat cerebral cortex nerve terminals: an NMDA receptor-independent mechanism.
Lu CW; Lin TY; Wang SJ
Neurochem Int; 2010 Sep; 57(2):168-76. PubMed ID: 20493916
[TBL] [Abstract][Full Text] [Related]
23. Coenzyme Q10 inhibits the release of glutamate in rat cerebrocortical nerve terminals by suppression of voltage-dependent calcium influx and mitogen-activated protein kinase signaling pathway.
Chang Y; Huang SK; Wang SJ
J Agric Food Chem; 2012 Dec; 60(48):11909-18. PubMed ID: 23167655
[TBL] [Abstract][Full Text] [Related]
24. Presynaptic mechanisms underlying the alpha-lipoic acid facilitation of glutamate exocytosis in rat cerebral cortex nerve terminals.
Wang SJ; Chen HH
Neurochem Int; 2007 Jan; 50(1):51-60. PubMed ID: 16949179
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase Cα in rat cerebral cortex nerve terminals.
Kuo JR; Wang CC; Huang SK; Wang SJ
Neurochem Int; 2012 Jan; 60(2):105-14. PubMed ID: 22142530
[TBL] [Abstract][Full Text] [Related]
26. σ-1 Receptor agonist SKF10047 inhibits glutamate release in rat cerebral cortex nerve endings.
Lu CW; Lin TY; Wang CC; Wang SJ
J Pharmacol Exp Ther; 2012 May; 341(2):532-42. PubMed ID: 22357973
[TBL] [Abstract][Full Text] [Related]
27. HTDP-2, a new synthetic compound, inhibits glutamate release through reduction of voltage-dependent Ca²⁺ influx in rat cerebral cortex nerve terminals.
Lin TY; Lu CW; Huang SK; Chou SS; Kuo YC; Chou SH; Tzeng WF; Leu CY; Huang RF; Liew YF; Wang SJ
Pharmacology; 2011; 88(1-2):26-32. PubMed ID: 21720189
[TBL] [Abstract][Full Text] [Related]
28. Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors.
Wang SJ; Wang KY; Wang WC; Sihra TS
J Neurosci Res; 2006 Nov; 84(7):1528-42. PubMed ID: 17016851
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by 'pathologically' elevated extraterminal K+ concentrations.
Raiteri L; Zappettini S; Milanese M; Fedele E; Raiteri M; Bonanno G
J Neurochem; 2007 Nov; 103(3):952-61. PubMed ID: 17662048
[TBL] [Abstract][Full Text] [Related]
30. Pyridoxine inhibits depolarization-evoked glutamate release in nerve terminals from rat cerebral cortex: a possible neuroprotective mechanism?
Yang TT; Wang SJ
J Pharmacol Exp Ther; 2009 Oct; 331(1):244-54. PubMed ID: 19628631
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by α2 adrenoceptor agonist dexmedetomidine.
Chiu KM; Lin TY; Lu CW; Wang SJ
Eur J Pharmacol; 2011 Nov; 670(1):137-47. PubMed ID: 21914443
[TBL] [Abstract][Full Text] [Related]
32. Src family tyrosine kinases differentially modulate exocytosis from rat brain nerve terminals.
Baldwin ML; Cammarota M; Sim AT; Rostas JA
Neurochem Int; 2006 Jul; 49(1):80-6. PubMed ID: 16500731
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of glutamate release by bupropion in rat cerebral cortex nerve terminals.
Lin TY; Yang TT; Lu CW; Wang SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):598-606. PubMed ID: 21216268
[TBL] [Abstract][Full Text] [Related]
34. Facilitation of glutamate release from rat cerebrocortical glutamatergic nerve terminals (synaptosomes) by phosphatidylserine and phosphatidylcholine.
Yang TT; Wang SJ
Synapse; 2009 Mar; 63(3):215-23. PubMed ID: 19072841
[TBL] [Abstract][Full Text] [Related]
35. Dimebon, an antihistamine drug, inhibits glutamate release in rat cerebrocortical nerve terminals.
Wang CC; Kuo JR; Wang SJ
Eur J Pharmacol; 2014 Jul; 734():67-76. PubMed ID: 24726847
[TBL] [Abstract][Full Text] [Related]
36. Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: possible relevance to neuroprotective interventions in schizophrenia.
Yang TT; Wang SJ
Synapse; 2008 Nov; 62(11):804-18. PubMed ID: 18720421
[TBL] [Abstract][Full Text] [Related]
37. Morphine inhibits glutamate exocytosis from rat cerebral cortex nerve terminals (synaptosomes) by reducing Ca2+ influx.
Yang TT; Hung CF; Lee YJ; Su MJ; Wang SJ
Synapse; 2004 Feb; 51(2):83-90. PubMed ID: 14618675
[TBL] [Abstract][Full Text] [Related]
38. Hispidulin inhibits the release of glutamate in rat cerebrocortical nerve terminals.
Lin TY; Lu CW; Wang CC; Lu JF; Wang SJ
Toxicol Appl Pharmacol; 2012 Sep; 263(2):233-43. PubMed ID: 22759588
[TBL] [Abstract][Full Text] [Related]
39. Astaxanthin inhibits glutamate release in rat cerebral cortex nerve terminals via suppression of voltage-dependent Ca(2+) entry and mitogen-activated protein kinase signaling pathway.
Lin TY; Lu CW; Wang SJ
J Agric Food Chem; 2010 Jul; 58(14):8271-8. PubMed ID: 20593829
[TBL] [Abstract][Full Text] [Related]
40. Presynaptic cross-talk of beta-adrenoreceptor and 5-hydroxytryptamine receptor signalling in the modulation of glutamate release from cerebrocortical nerve terminals.
Wang SJ; Coutinho V; Sihra TS
Br J Pharmacol; 2002 Dec; 137(8):1371-9. PubMed ID: 12466248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
